Assessment and prevention of cardiovascular disease
You must score at least 70% in this module to pass. Ensure you have read ‘Assessment and prevention of cardiovascular disease’ before attempting to complete the module.
This module can be taken up to three times. Once you have passed, you can view the correct answers and download a certificate as a record of your learning.
Additional CPD modules are available in the ‘My CPD’ section of your account.
Quiz Summary
0 of 15 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 15 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- Current
- Review
- Answered
- Correct
- Incorrect
- Question 1 of 15
1. Question
What proportion of deaths in the UK are owing to cardiovascular disease?
CorrectIncorrect - Question 2 of 15
2. Question
An NHS health check should be offer to a person:
CorrectIncorrect - Question 3 of 15
3. Question
A risk assessment tool such as QRISK 3 or ASSIGN will help quantify a person’s risk of a heart attack, angina, stroke, or transient ischaemic attack in the next 10 years. In which patient group would it be inappropriate to use a the QRISK 3 assessment tool?
CorrectIncorrect - Question 4 of 15
4. Question
Compared to QRISK 2, which of the following is included in QRISK 3?
CorrectIncorrect - Question 5 of 15
5. Question
According to National Institute for Health and Care Excellence guidance, when using the QRISK 3 tool, at what level of cardiovascular disease risk might you offer a patient a statin for primary prevention?
CorrectIncorrect - Question 6 of 15
6. Question
Lifestyle modification should play a central role in reducing cardiovascular risk, both at a population and individual level. Semaglutide has recently been approved by the National Institute for Health and Care Excellence as an option for weight management, including weight loss and weight maintenance. The recommended maintenance dose is:
CorrectIncorrect - Question 7 of 15
7. Question
Cutting down on saturated fat and replacing with unsaturated fats is recommended to help lower cholesterol. Which of the following oils is high in saturated fat and should be avoided?
CorrectIncorrect - Question 8 of 15
8. Question
In the UK, in 2021, 13.3% of people aged 18 years and over smoked cigarettes. In which age-group is the prevalence of smoking the highest?
CorrectIncorrect - Question 9 of 15
9. Question
According to the National Institute for Health and Care Excellence, which of the following would not be considered a high-potency statin?
CorrectIncorrect - Question 10 of 15
10. Question
There are some significant drug interactions with statins. With which of the following combinations should the dose of atorvastatin be limited to a maximum of 10mg once per day?
CorrectIncorrect - Question 11 of 15
11. Question
Which of the following blood tests may be helpful if a patient reports muscle-related side effects when taking a statin?
CorrectIncorrect - Question 12 of 15
12. Question
If the required reduction in low-density-lipoprotein (LDL) cholesterol is not achieved with a statin, ezetimibe is often added to the treatment regime. What additional reduction in LDL-cholesterol might you expect by adding ezetimibe to statin treatment?
CorrectIncorrect - Question 13 of 15
13. Question
Which of the following is a common side-effect of bempedoic acid?
CorrectIncorrect - Question 14 of 15
14. Question
Inclisaran was introduced in 2021 and requires administration by subcutaneous injection. The recommended dosing schedule is:
CorrectIncorrect - Question 15 of 15
15. Question
Following the publication of the REDUCE-IT trial results, the National Institute for Health and Care Excellence recommends icosapent ethyl as an option in patients for:
CorrectIncorrect